Full Text View
Tabular View
No Study Results Posted
Related Studies
Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia
This study has been completed.
Study NCT00029380   Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: January 10, 2002   Last Updated: September 30, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hematologic Diseases
Anemia, Sickle Cell
Beta-Thalassemia
Additional conditions recognized in this trial
Anemia
Thalassemia
More general conditions related to this trial
Anemia, Hemolytic
Anemia, Hemolytic, Congenital
Genetic Diseases, Inborn
Hemoglobinopathies
Interventions listed in this trial
Sangstat
Cyclophosphamide
Busulfan
Mycophenolate Mofetil
Cyclosporine
Cord Blood Transplantation
Additional drug interventions recognized in this trial
Cyclosporins
Mycophenolic Acid
More general drug interventions related to this trial
Alkylating Agents
Anti-Infective Agents
Antibiotics, Antineoplastic
Antifungal Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antirheumatic Agents
Dermatologic Agents
Enzyme Inhibitors
Immunologic Factors
Immunosuppressive Agents
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services